| 901 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2025 |
Standard Therapy |
Poland |
6 |
| 902 |
Bone Marrow |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
Poland |
44 |
| 903 |
Bone Marrow |
Allogeneic |
Paroxysmal Nocturnal Hemoglobinuria |
Hematology |
2025 |
Standard Therapy |
Poland |
25 |
| 904 |
Bone Marrow |
Allogeneic |
Juvenile Myelomonocytic Leukemia |
Hematology |
2025 |
Standard Therapy |
Poland |
4 |
| 905 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2025 |
Standard Therapy |
USA |
21 |
| 906 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2025 |
Standard Therapy |
Italy |
12 |
| 907 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2025 |
Standard Therapy |
Hungary |
10 |
| 908 |
Bone Marrow |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
Czechia |
68 |
| 909 |
Bone Marrow |
Allogeneic |
Adrenoleukodystrophy |
Hematology |
2025 |
Standard Therapy |
Poland |
53 |
| 910 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2025 |
Standard Therapy |
Germany |
4 |
| 911 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2025 |
Standard Therapy |
France |
4 |
| 912 |
Bone Marrow |
Allogeneic |
Paroxysmal Nocturnal Hemoglobinuria |
Hematology |
2025 |
Standard Therapy |
Norway |
18 |
| 913 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2025 |
Standard Therapy |
Spain |
24 |
| 914 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2025 |
Standard Therapy |
Belarus |
5 |
| 915 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2025 |
Standard Therapy |
Germany |
53 |
| 916 |
Bone Marrow |
Allogeneic |
diamond-Balckfan anemia |
Hematology |
2025 |
Standard Therapy |
Germany |
11 |
| 917 |
Bone Marrow |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
Poland |
57 |
| 918 |
Bone Marrow |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
Poland |
61 |
| 919 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2025 |
Standard Therapy |
France |
3 |
| 920 |
Bone Marrow |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
Belarus |
1 |
| 921 |
Bone Marrow |
Allogeneic |
pB-Acute Lymphoblastic Leukemia |
Hematology |
2025 |
Standard Therapy |
Germany |
15 |
| 922 |
Bone Marrow |
Allogeneic |
OHID XIAP – Other Histiocytic Disorders / X-Linked Inhibitor of Apoptosis Protein |
Hematology |
2025 |
Standard Therapy |
Switzerland |
2 |
| 923 |
Bone Marrow |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
USA |
46 |
| 924 |
Bone Marrow |
Allogeneic |
Acquired Idiopathic Sideroblastic Anemia |
Hematology |
2025 |
Standard Therapy |
Russian Federation |
5 |
| 925 |
Bone Marrow |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
USA |
10 |
| 926 |
Bone Marrow |
Allogeneic |
Hodgkin Lymphoma |
Hematology |
2025 |
Standard Therapy |
USA |
47 |
| 927 |
Bone Marrow |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
CROATIA |
11 |
| 928 |
Bone Marrow |
Allogeneic |
Juvenile myelomonocytic leukemia |
Hematology |
2025 |
Standard Therapy |
Poland |
5 |
| 929 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2025 |
Standard Therapy |
Brazil |
12 |
| 930 |
Bone Marrow |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
Australia |
8 |
| 931 |
Bone Marrow |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
Italy |
3 |
| 932 |
Bone Marrow |
Allogeneic |
Myelodysplatic Syndrome |
Hematology |
2025 |
Standard Therapy |
USA |
60 |
| 933 |
Bone Marrow |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
Russia |
36 |
| 934 |
Bone Marrow |
Allogeneic |
Thalassemia major |
Hematology |
2025 |
Standard Therapy |
Turkey |
10 |
| 935 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2025 |
Standard Therapy |
Poland |
58 |
| 936 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2025 |
Standard Therapy |
Poland |
2 |
| 937 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2025 |
Standard Therapy |
USA |
18 |
| 938 |
Bone Marrow |
Allogeneic |
Other Non-Malignant Disease, Specify |
Hematology |
2025 |
Standard Therapy |
USA |
17 |
| 939 |
Bone Marrow |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
USA |
15 |
| 940 |
Bone Marrow |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
Italy |
15 |
| 941 |
Bone Marrow |
Allogeneic |
aplastic anemia |
Hematology |
2025 |
Standard Therapy |
Belgium |
36 |
| 942 |
Bone Marrow |
Allogeneic |
Primary Refractory |
Hematology |
2025 |
Standard Therapy |
Ireland |
27 |
| 943 |
Bone Marrow |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
USA |
39 |
| 944 |
Bone Marrow |
Allogeneic |
Sickle Cell Disease (SCD) |
Hematology |
2025 |
Standard Therapy |
Italy |
8 |
| 945 |
Bone Marrow |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
USA |
68 |
| 946 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2025 |
Standard Therapy |
USA |
58 |
| 947 |
Bone Marrow |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
Poland |
1 |
| 948 |
Bone Marrow |
Allogeneic |
Severe Combined Immunodeficiency |
Hematology |
2025 |
Standard Therapy |
United Kingdom |
13 |
| 949 |
Bone Marrow |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
Denmark |
38 |
| 950 |
Bone Marrow |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
USA |
17 |
| 951 |
Bone Marrow |
Allogeneic |
Fanconi Anemia |
Hematology |
2025 |
Standard Therapy |
Poland |
11 |
| 952 |
Bone Marrow |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
Poland |
9 |
| 953 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2025 |
Standard Therapy |
USA |
3 |
| 954 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2025 |
Standard Therapy |
France |
9 |
| 955 |
Bone Marrow |
Allogeneic |
Fanconi Anemia |
Hematology |
2025 |
Standard Therapy |
Poland |
8 |
| 956 |
Bone Marrow |
Allogeneic |
Immune Deficiency |
Hematology |
2025 |
Standard Therapy |
United Kingdom |
10 |
| 957 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2025 |
Standard Therapy |
Germany |
12 |
| 958 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2025 |
Standard Therapy |
USA |
20 |
| 959 |
Bone Marrow |
Allogeneic |
Hodgkin Lymphoma |
Hematology |
2025 |
Standard Therapy |
Turkey |
17 |
| 960 |
Bone Marrow |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
France |
13 |
| 961 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2025 |
Standard Therapy |
Canada |
22 |
| 962 |
Bone Marrow |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
Germany |
15 |
| 963 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2025 |
Standard Therapy |
Italy |
8 |
| 964 |
Bone Marrow |
Allogeneic |
Inherited Immune System Disorder |
Hematology |
2025 |
Standard Therapy |
France |
3 |
| 965 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2025 |
Standard Therapy |
Italy |
2 |
| 966 |
Bone Marrow |
Allogeneic |
Bone Marrow Failure |
Hematology |
2025 |
Standard Therapy |
Netherlands |
23 |
| 967 |
Bone Marrow |
Allogeneic |
Chronic Granulomatous Disease |
Hematology |
2025 |
Standard Therapy |
Italy |
6 |
| 968 |
Bone Marrow |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
Poland |
5 |
| 969 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
Germany |
58 |
| 970 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
USA |
34 |
| 971 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
Italy |
61 |
| 972 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome/Myeloproliferative neoplasm |
Hematology |
2025 |
Standard Therapy |
NETHERLANDS |
62 |
| 973 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
Austria |
68 |
| 974 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
Germany |
70 |
| 975 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
Germany |
66 |
| 976 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
USA |
77 |
| 977 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
Ukraine |
12 |
| 978 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
Germany |
58 |
| 979 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
USA |
67 |
| 980 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2025 |
Standard Therapy |
Poland |
4 |
| 981 |
Apheresis |
Allogeneic |
Myelofibrosis Myeloid Metaplasia |
Hematology |
2025 |
Standard Therapy |
USA |
73 |
| 982 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
Germany |
56 |
| 983 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2025 |
Standard Therapy |
Italy |
50 |
| 984 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
Poland |
39 |
| 985 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
Lithuania |
43 |
| 986 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2025 |
Standard Therapy |
Poland |
66 |
| 987 |
Apheresis |
Allogeneic |
Multiple Myeloma |
Hematology |
2025 |
Standard Therapy |
USA |
61 |
| 988 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
Austria |
55 |
| 989 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
Italy |
69 |
| 990 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
Denmark |
67 |
| 991 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2025 |
Standard Therapy |
United Kingdom |
75 |
| 992 |
Apheresis |
Allogeneic |
T – cell Acute Lymphoblastic Leukemia |
Hematology |
2025 |
Standard Therapy |
Poland |
24 |
| 993 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2025 |
Standard Therapy |
Belgium |
68 |
| 994 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2025 |
Standard Therapy |
Ukraine |
42 |
| 995 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2025 |
Standard Therapy |
USA |
50 |
| 996 |
Apheresis |
Allogeneic |
Prolymphocytic Leukemia |
Hematology |
2025 |
Standard Therapy |
USA |
62 |
| 997 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2025 |
Standard Therapy |
United Kingdom |
62 |
| 998 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2025 |
Standard Therapy |
USA |
69 |
| 999 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
Germany |
85 |
| 1000 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
USA |
54 |